Cargando…

How to provide an effective primary health care in fighting against severe acute respiratory syndrome: The experiences of two cities

OBJECTIVES: This study was designed to compare the response and management of severe acute respiratory syndrome (SARS) by the family physicians of the Hong Kong and the Toronto health systems, and to provide evidence to improve health policy and practices in a newly emerging infectious disease. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, William C.W., Wong, Samuel Y.S., Lee, Albert, Goggins, William B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. 2007
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132727/ https://www.ncbi.nlm.nih.gov/pubmed/17276791 http://dx.doi.org/10.1016/j.ajic.2006.06.009

Ejemplares similares

Socioeconomic Disparities in Severe Acute Respiratory Syndrome Coronavirus 2 Serological Testing and Positivity in New York City
por: Lieberman-Cribbin, Wil, et al.
Publicado: (2021)

Antibiotic Prescribing Practices for Upper Respiratory Tract Infections Among Primary Care Providers: A Descriptive Study
por: Chandra Deb, Liton, et al.
Publicado: (2022)

Appraisal of recommended respiratory infection control practices in primary care and emergency department settings
por: Turnberg, Wayne, et al.
Publicado: (2008)

Reduced Odds of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Vaccination Among New York City Adults, July 2021–November 2021
por: Levin-Rector, Alison, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses
por: Lawrenz, Jan, et al.
Publicado: (2022)

New-Onset Dementia Among Survivors of Pneumonia Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Qureshi, Adnan I, et al.
Publicado: (2022)

Feasibility and Acceptability of Home-Collected Samples for Human Immunodeficiency Virus Preexposure Prophylaxis and Severe Acute Respiratory Syndrome Coronavirus 2 Laboratory Tests in San Francisco Primary Care Clinics
por: Saberi, Parya, et al.
Publicado: (2022)

Pfizer-BioNTech Coronavirus Disease 2019 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Long-term Care Facility Staff With and Without Prior Infection in New York City, January–June 2021
por: Peebles, Kathryn, et al.
Publicado: (2023)

Infection-Induced Immunity Is Associated With Protection Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Decreased Infectivity
por: Frutos, Aaron M, et al.
Publicado: (2023)

Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein
por: Upasani, Vinit, et al.
Publicado: (2023)

Private ownership of primary care providers associated with patient perceived quality of care: A comparative cross-sectional survey in three big Chinese cities
por: Wei, Xiaolin, et al.
Publicado: (2017)

Preventive Efficacy of Tenofovir/Emtricitabine Against Severe Acute Respiratory Syndrome Coronavirus 2 Among Pre-Exposure Prophylaxis Users
por: Ayerdi, Oskar, et al.
Publicado: (2020)

Strong CD4(+) T-Cell Responses to Ancestral and Variant Spike Proteins Are Established by NVX-CoV2373 Severe Acute Respiratory Syndrome Coronavirus 2 Primary Vaccination
por: Fries, Louis, et al.
Publicado: (2023)

Fighting against COVID-19: preparedness and implications on clinical practice in primary care in Shenzhen, China
por: Tse, Desiree Man-Sik, et al.
Publicado: (2020)

Comparison of the Etiology of Viral Respiratory Illnesses in Inner-City and Suburban Infants
por: Gern, James E., et al.
Publicado: (2012)

A Potent Recombinant Polyclonal Antibody Therapeutic for Protection Against New Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern
por: Wayham, Nicholas P, et al.
Publicado: (2023)

Validity of Self-testing at Home With Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Detection by Lateral Flow Immunoassay
por: Atchison, Christina J, et al.
Publicado: (2022)

Comparison of primary care experiences among adults in general outpatient clinics and private general practice clinics in Hong Kong
por: Wong, Samuel YS, et al.
Publicado: (2010)

Racial, Ethnic, and Geographic Disparities in Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Test Positivity in North Carolina
por: Turner, Nicholas A, et al.
Publicado: (2020)

Changes in Population Immunity Against Infection and Severe Disease From Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variants in the United States Between December 2021 and November 2022
por: Klaassen, Fayette, et al.
Publicado: (2023)

Singing Is a Risk Factor for Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Case-Control Study of Karaoke-Related Coronavirus Disease 2019 Outbreaks in 2 Cities in Hokkaido, Japan, Linked by Whole Genome Analysis
por: Nakashita, Manami, et al.
Publicado: (2022)

Efficacy of Messenger RNA–1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021
por: Stephenson, Kathryn E, et al.
Publicado: (2023)

Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England
por: Grint, Daniel J, et al.
Publicado: (2021)

Epidemiological Characteristics and Risk Factors of Severe Fever With Thrombocytopenia Syndrome in Yantai City, Shandong Province
por: Hou, Shuting, et al.
Publicado: (2023)

Severity of Respiratory Syncytial Virus Lower Respiratory Tract Infection With Viral Coinfection in HIV-Uninfected Children
por: Mazur, Natalie I., et al.
Publicado: (2017)

Influenza A and Respiratory Syncytial Virus Trigger a Cellular Response That Blocks Severe Acute Respiratory Syndrome Virus 2 Infection in the Respiratory Tract
por: Dee, Kieran, et al.
Publicado: (2022)

Antimicrobial Management of Respiratory Infections in Severe Acute Respiratory Syndrome Coronavirus 2 Patients: Clinical and Antimicrobial Stewardship Programs Conundrums
por: Goldstein, Ellie J C, et al.
Publicado: (2020)

Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022
por: Hoeve, Christina E, et al.
Publicado: (2023)

Exhaled Breath Aerosol Shedding of Highly Transmissible Versus Prior Severe Acute Respiratory Syndrome Coronavirus 2 Variants
por: Lai, Jianyu, et al.
Publicado: (2022)

Understanding Early Pandemic Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in a Medical Center by Incorporating Public Sequencing Databases to Mitigate Bias
por: Turcinovic, Jacquelyn, et al.
Publicado: (2022)

eConsultations to Infectious Disease Specialists: Questions Asked and Impact on Primary Care Providers’ Behavior
por: Murthy, Ruchi, et al.
Publicado: (2017)

Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity
por: Brown, Jennifer A, et al.
Publicado: (2023)

Probiotics: How Effective Are They in the Fight against Obesity?
por: Mazloom, Kiran, et al.
Publicado: (2019)

Initial Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load Is Associated With Disease Severity: A Retrospective Cohort Study
por: Souverein, Dennis, et al.
Publicado: (2022)

Investigation of Blood Plasma Viral Nucleocapsid Antigen as a Marker of Active Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection
por: Damhorst, Gregory L, et al.
Publicado: (2023)

Host Predictors of Broadly Cross-Reactive Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern Differ Between Infection and Vaccination
por: Tang, Li, et al.
Publicado: (2021)

BNT162b2 Effectiveness Against Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2 in Adolescents Aged 12–17 Years, by Dosing Interval and Duration
por: Ionescu, Iulia G, et al.
Publicado: (2023)

Similar Antibody Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Individuals Living Without and With Human Immunodeficiency Virus on Antiretroviral Therapy During the First South African Infection Wave
por: Snyman, Jumari, et al.
Publicado: (2021)

A Distinct Phylogenetic Cluster of Indian Severe Acute Respiratory Syndrome Coronavirus 2 Isolates
por: Banu, Sofia, et al.
Publicado: (2020)

Modeling transmission dynamics of severe acute respiratory syndrome coronavirus 2 in São Paulo, Brazil
por: da Cruz, Pedro Alexandre, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d429p5kp11o9e3evrv8mlgu6a3